{"disease":{"id":"systemic-lupus-erthematosus","name":"systemic lupus erthematosus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03952624","title":"Patient-Centered Assessment of Symptoms and Outcomes","phase":"","overall_status":"RECRUITING","enrollment_count":692,"lead_sponsor_name":"National Center for Complementary and Integrative Health (NCCIH)","has_results":false},{"nct_id":"NCT06599658","title":"COVID-19 Booster and IIV Schedule in Immunocompromised Hosts","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":660,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT07188285","title":"Mass Spectrometry-based Immune Profiling in Autoimmune Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07086989","title":"Cardiovascular Risk in Children With Chronic Conditions Study","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Semmelweis University","has_results":false},{"nct_id":"NCT07136389","title":"Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":135,"lead_sponsor_name":"Biocad","has_results":false},{"nct_id":"NCT07024082","title":"Water-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"MTI University","has_results":false},{"nct_id":"NCT07278609","title":"The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT06842810","title":"Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":95,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06586359","title":"Bone Mineral Density in Patients With Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical Criteria","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":78,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06757725","title":"Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Kasr El Aini Hospital","has_results":false},{"nct_id":"NCT07348055","title":"A Study of GR1803 in Systemic Lupus Erythematosus","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"Genrix (Shanghai) Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07225543","title":"2-HOBA in Systemic Lupus Erythematosus","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT06652256","title":"Fatigue in Systemic Lupus Erythematosus","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT06792799","title":"Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT07491900","title":"A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Hinge Bio","has_results":false},{"nct_id":"NCT01716312","title":"Omalizumab for Lupus","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","has_results":false},{"nct_id":"NCT06821659","title":"Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06828042","title":"Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Peking University Third Hospital","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}